(Press-News.org) Bethesda, MD (June 12, 2014) — The gluten-specific enzyme ALV003 reduces a patient's exposure to gluten and its potential harm, according to a new phase 2 study appearing in Gastroenterology1, the official journal of the American Gastroenterological Association. This study is the first to find that a non-dietary intervention can potentially benefit celiac disease patients.
Study participants were put on an everyday gluten-free diet, challenged with up to 2 grams of gluten daily (equivalent to approximately one half of a standard slice of bread in the U.S.). Researchers found that daily oral administration of ALV003, at the time of gluten ingestion, decreased gluten-induced injury to the small intestine. The treatment appeared to be well tolerated. Gastrointestinal symptoms, such as nausea and abdominal pain, were greater in the placebo group compared with those receiving active treatment.
"Total avoidance of gluten is, at best, challenging," said lead study author, Marja-Leena Lahdeaho, University of Tampere, Tampere University Hospital, Finland. "The potential of ALV003 for celiac disease is significant given that ongoing exposure to low levels of gluten can cause patients to experience persistent symptoms and chronic intestinal inflammation, despite following a strict gluten-free diet."
Gluten is widely used in the food and other industries. Cross contamination during food processing is difficult to avoid and the labeling of food products can be inaccurate, misleading or incorrect. The gluten-free diet is socially troublesome, expensive and compliance is problematic. Additionally, traces of gluten can be found in common items such as envelope glue and makeup. These challenges lead to consumption of small amounts of gluten in even the most cautious patients. Thus, there is a need for the development of a pharmacologic therapy that will work with or replace a gluten-free diet.
As the first evidence of a therapeutic intervention for celiac disease meeting primary endpoints, this randomized, double-blind, placebo-controlled clinical trial is a welcomed addition to celiac research. Future studies are warranted before ALV003 can come to market; a 500-person multi-center trial is currently ongoing.
INFORMATION:
For more information on celiac disease, read AGA's patient brochure.
Research funding for this study was provided by Alvine Pharmaceuticals, Inc.
About the AGA Institute
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. http://www.gastro.org.
About Gastroenterology
Gastroenterology, the official journal of the AGA Institute, is the most prominent scientific journal in the specialty and is in the top 1 percent of indexed medical journals internationally. The journal publishes clinical and basic science studies of all aspects of the digestive system, including the liver and pancreas, as well as nutrition. The journal is abstracted and indexed in Biological Abstracts, Current Awareness in Biological Sciences, Chemical Abstracts, Current Contents, Excerpta Medica, Index Medicus, Nutrition Abstracts and Science Citation Index. For more information, visit http://www.gastrojournal.org.
Like AGA and Gastroenterology on Facebook.
Join AGA on LinkedIn.
Follow us on Twitter @AmerGastroAssn.
Check out our videos on YouTube.
1 Lähdeaho, Marja-Leena et al. Glutenase ALV003 Attenuates Gluten-Induced Mucosal Injury in Patients With Celiac Disease. Gastroenterology 2014; 146(7): 1649 - 1658; http://www.gastrojournal.org/article/S0016-5085(14)00242-X.
Potential new treatment may protect celiac patients from gluten-induced injury
2014-06-12
ELSE PRESS RELEASES FROM THIS DATE:
First articles published in new Journal of Medical Imaging
2014-06-12
BELLINGHAM, Washington (USA) — The Journal of Medical Imaging (JMI) has launched, with freely accessible articles on new research on earlier and more accurate diagnosis and monitoring of cancer and other diseases, image quality assessment, 3D imaging, and other topics. Published by SPIE, the international society for optics and photonics, the quarterly journal is available online in the SPIE Digital Library, with each peer-reviewed article published as it is approved. JMI will also be issued in print.
JMI covers fundamental and translational research and applications ...
Climate change winners and losers
2014-06-12
The Antarctic Peninsula, the northern most region of Antarctica, is experiencing some of the most dramatic changes due to climate warming, including population declines of some penguin species.
This is not the first time that region has felt the effects of climate warming. How did penguins respond to the melting of snow and ice cover 11,000 years ago at the end of the last Ice Age?
Today, scientists have traced the genetics of modern penguin populations back to their early ancestors from the last Ice Age to better understand how three Antarctic penguin species – gentoo, ...
Rise and fall of prehistoric penguin populations charted
2014-06-12
A study of how penguin populations have changed over the last 30,000 years has shown that between the last ice age and up to around 1,000 years ago penguin populations benefitted from climate warming and retreating ice. This suggests that recent declines in penguins may be because ice is now retreating too far or too fast.
An international team, led by scientists from the Universities of Southampton and Oxford, has used a genetic technique to estimate when current genetic diversity arose in penguins and to recreate past population sizes. Looking at the 30,000 years before ...
A picture's worth a thousand words
2014-06-12
For nearly 100 years, we have known that type 1 diabetes (T1D) is a disease fundamentally about the progressive loss of insulin-producing beta cells, but measuring that loss has continued to elude researchers—at least until now.
In a recent scientific publication, JDRF-funded researchers used a radiotracer or marker and PET (Positron Emission Tomography) scanning as a non-invasive technique to follow changes in how many active beta cells a person has. Dr. Olle Korsgren and his colleagues at the University of Uppsala in Sweden used the technique in a clinical study ...
Alcohol abuse damage in neurones at a molecular scale identified for first time
2014-06-12
This news release is available in Spanish.
Joint research between the University of the Basque Country (UPV/EHU) and the University of Nottingham has identified, for the first time, the structural damage caused at a molecular level to the brain by the chronic excessive abuse of alcohol. In concrete, the research team has determined the alterations produced in the neurones of the prefrontal zone of the brain (the most advanced zone in terms of evolution and that which controls executive functions such as planning, designing strategies, working memory, selective ...
David and Goliath: How a tiny spider catches much larger prey
2014-06-12
In nature, it is very rare to find a proverbial much smaller David able to overpower and kill a Goliath for supper. This is exactly the modus operandi of a solitary tiny spider from the Negev desert in Israel that routinely kills ants up to almost four times its own size. Details about how it attacks and kills its prey with a venomous bite is published in Springer's journal Naturwissenschaften – The Science of Nature. The study was led by Stano Pekár of Masaryk University in the Czech Republic.
Pekár's team observed the natural prey and predatory behavior of the minute ...
Survivors of childhood liver transplant at risk of becoming 'skinny fat'
2014-06-12
New research reports that survivors of childhood liver transplant remain nutritionally compromised over the long-term. Findings published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, indicate that the recipients' return to normal weight post-transplant was due to an increase in fat mass as body cell mass remained low, indicating a slim body composition with little lean muscle mass or "skinny fat."
Children with end-stage liver disease may be malnourished due to inadequate ...
Scientists closing in on new obesity drug
2014-06-12
Obesity and diabetes are among the fastest growing health problems in the world, and the hunt is in for a pill that can fight the problem. Now a Danish/British team has come up with a smart tool that will speed up the scientific hunting process, and we may be one step closer to a pill against obesity.
The body has a variety of functions that decide if we get overweight or not. For instance hormones control our appetite and the uptake of food. In recent years science has taken on the quest of investigating these physiological functions and finding a medical way to fight ...
Children showing signs of social withdrawal in risk of internalized distress
2014-06-12
Children are showing signs of social withdrawal are more susceptible to parental influences than others. These children were also more prone to distress caused by the impacts of guilt-inducing parenting.
The researchers of the University of Jyväskylä, Finland, have found that children showing signs of social withdrawal are more susceptible to parental influences than others. The researchers followed up about 300 children across the first three years of primary school and monitored the children's social skills and problem behaviors. At the same time, mothers' and fathers' ...
Recreational football can treat hypertensive and type 2 diabetes patients
2014-06-12
The studies, published in the acclaimed Scandinavian Journal of Medicine & Science in Sports, show that 24 weeks of twice-weekly recreational football training sessions lower blood pressure and improves heart function in men with high blood pressure and men with type 2 diabetes. Furthermore, men with type 2 diabetes lost 12 % of their abdominal fat and reduced their blood sugar 20% more than inactive control subjects.
These effects are likely to reduce the risk of developing heart diseases including heart failure and myocardial infarction, and the participants had a reduced ...